Summary Squamous cell carcinoma of the cervix (SCC) is preceded by a premalignant condition known as cervical intraepithelial neoplasia (CIN). The majority of cases of CIN regress spontaneously; however, methods are needed to identify those lesions likely to progress. Increased blood vessel density, signifying angiogenesis, is an independent prognostic indicator in a number of cancers, although little is known about its significance in premalignant lesions. The aim of the present study was to determine the relationship between vessel density, expression of the potent angiogenic factor vascular endothelial growth factor (VEGF) and CIN grade. Using immunohistochemistry, mean vessel density (MVD) and VEGF expression were assessed in samples from 54 patients who had undergone cone biopsy for CIN or hysterectomy for SCC and from 16 patients with no cervical pathology. There were significant increases in MVD and VEGF expression from normal cervix through CIN I to CIN IlIl to invasive SCC, but no difference in mean vessel diameter between groups. There was a strong correlation between mean vessel density and VEGF expression, and both were associated with histological grade of CIN. The original MVDs for a small group of patients later presenting with recurrent disease were found to be equal to or greater than the mean for their histological grade. We conclude that the onset of angiogenesis is an early event in premalignant changes of the cervix due, in part, to enhanced expression of VEGF by the abnormal epithelium.
Carcinoma of the cervix remains a major cause of mortality and morbidity in the UK with approximately 4000 new cases diagnosed each year. Cervical intraepithelial neoplasia (CIN) is a precursor to carcinoma of the cervix and is subdivided into three grades, CIN I, CIN II and CIN III. The malignant potential of the most severe form, CIN grade III (carcinoma in situ), is thought to be approximately 36% over 20 years (Mclndoe et al, 1984) . Less is understood about the malignant potential of minor CIN (grades I and II), and up to 50% of these lesions may regress spontaneously (Robertson et al, 1988) . There is considerable controversy surrounding the management of patients with mild abnormalities (Shafi, 1994) , many of which are excised or ablated -treatment normally recommended for CIN III. Current screening methods involve Papanicolaou smears and colposcopic referral for smear abnormalities. Colposcopic examination of the cervix relies in part on identification of vascular abnormalities, such as punctation and mosaicism (Sillman et al, 1981) , which are indicative of new blood vessel growth that has penetrated the epithelium.
Angiogenesis is essential for solid tumour growth (Folkman, 1990) and metastasis (Olivarez, 1994) . Furthermore, several studies have now correlated angiogenesis, as indicated by increased blood vessel density, with poor prognosis in several types of solid tumour, including those of breast (Weidner et al, 1991 (Weidner et al, , 1992 Horak et al, 1992; Toi et al, 1993; Axelsson et al, 1995) , of prostate (Weidner et al, 1993) and of cervix (Schlenger et al, 1995; Wiggins et al, 1995) , and malignant melanoma (Srivastava et al, 1988) . Vascular endothelial growth factor (VEGF) is a key angiogenic factor and regulator of endothelial cell function (Thomas, 1996) , acting through two tyrosine kinase receptors flt-I and KDR (Plate et al, 1994a; Mustonen and Alitalo, 1995) . VEGF is expressed during physiological angiogenesis, including embryological development , wound healing (Frank et al, 1995) and in the endometrium (CharnockJones et al, 1993) , and also plays a major role in tumour angiogenesis (Plate et al, 1992) . Underlining the importance of VEGF, experiments show that tumour growth and metastasis are inhibited by systemic administration of monoclonal antibodies against VEGF (Kim et al, 1993) or its receptor KDR (Rockwell and Goldstein, 1995) and by suppression of normal receptor function in murine tumour models (Millauer, 1994) .
Angiogenesis also occurs in premalignant conditions of breast, colon and cervix before the onset of frank invasion (Guidi et al, 1994; Bossi et al, 1995; Guidi et al, 1995) . Indeed, the occurrence of gross vascular changes in CIN III as well as in invasive disease has been known for many years (Stafl and Mattingly, 1975) . Such changes suggest that the angiogenic process is associated with progression of intraepithelial neoplasia to invasive SCC. Two studies have demonstrated that microvessel density increases progressively with grade of CIN (Smith-McCune and Weidner, 1994; Guidi et al, 1995) . More recently, another study (Abulafia et al, 1996) found no evidence of increased stromal microvessel count in carcinoma in situ compared with controls, although there was a significant increase in microinvasive disease. In the current study, we examine the relationship between MVD, CIN grade and 
Mean vessel density (MVD)
The vWF-positive blood vessel count was assessed with a x20 objective (plus xIO eyepiece; equal to x200 magnification) using a square graticule of area 0.25 mm2, positioned beneath the area of identifiable abnormality. All positive vessels within the grid were counted. Each specimen had three counts performed beneath separate areas of histological abnormality by the same investigator. (Table 4) . 
DISCUSSION
In cervical carcinoma, the prognostic role of angiogenesis is unclear; some studies suggest that high blood vessel density predicts for improved survival when associated with radiotherapy (Siracka et al, 1994) or intra-arterial chemotherapy (Kohno et al, 1993) , while others have found that angiogenesis per se does not relate to stage of disease or prognosis (Bossi et al, 1995 , Rutgers et al, 1995 . However, conflicting reports suggest that microvessel Figure 4 Relationship of vascular endothelial growth factor (VEGF) expression to mean vessel density (MVD). These parameters were strongly associated (P = 0.007, MANOVAR) density is related to vascular space involvement and that high density is a predictor of tumour recurrence in patients who are node negative and have no vascular space involvement (Schlenger et al, 1995; Wiggins et al, 1995) . Several in vitro and in vivo studies have shown that the onset of angiogenesis occurs before tumour invasion in a variety of tumour types (Folkman et al, 1989; Guidi et al, 1994; Bossi et al, 1995) . Our data demonstrate that vessel density is significantly increased in early CIN (grade I) compared with normal tissue, which suggests that the initiation of the angiogenic process occurs early in this disease process. Punctation and mosaicism of the epithelium are colposcopic indicators of CIN III, thus gross as well as microscopic vascular changes are already apparent at a late premalignant stage. However, the presence of gross vascular changes is unusual in low-grade CIN. The microvascular changes that we observed in the stroma early in the disease process may represent precursors of those changes seen at later times. We also found that mean vessel diameter is unchanged irrespective of histological grade, suggesting that the primary effect of the angiogenic stimulus is to increase vessel number generally, without altering the distribution of vessel sizes.
VEGF, an endothelium specific mitogen and potent mediator of vascular permeability, is expressed in normal tissues, such as endometrium (Charnock-Jones et al, 1993) , and solid tumours frequently exhibit high levels of VEGF compared with their normal counterparts (Brown et al, 1993 Boocock et al, 1995; Wizigmann-Voos et al, 1995) . We have demonstrated by immunohistochemistry that epithelial expression of VEGF protein increases with grade of CIN and vessel density. We found enhanced expression of VEGF within abnormal areas of the squamous epithelium, which concurs with the study evidence of HPV infection (Lehtinen et al, 1996) . A potential link between HPV infection and angiogenesis may rest with the p53 tumour-suppressor gene and its relationship to VEGF expression. E6 protein, associated with HPV subtypes 16 and 18, functionally inactivates p53 (Huibregtse et al, 1993) . One study has suggested that the presence of functional wild-type p53 suppresses VEGF expression (Mukhopadhay et al, 1995) and by implication that VEGF expression may be increased in tumours expressing mutant p53. Another study suggests that p53 mutation may 'prime' tumour cells to secrete VEGF in response to other factors (Kieser et al, 1994) . In contrast, Plate et al (1994b) did not find an association between VEGF expression and p53 mutation in glioma. Therefore, while there may in some instances be coincidence of p53 mutation and VEGF expression, a causal relationship has not been established. Nevertheless, even if HPV E6 is implicated in this process, other undefined factors must be involved as not all patients with CIN III progress to invasive carcinoma and the incidence of HPV infection in the community is much higher than the incidence of CIN. Therefore, the presence of HPV infection per se in unlikely to provide information on the probability of recurrence or progression.
In view of the lack of known prognostic indicators, a finding of potential interest is the increasing range of MVD seen within each histological group. Such a distribution could have prognostic significance for disease progression. A very small number of patients with recurrent CIN had mean vessel densities higher than the mean for their group. Although none developed invasive SCC, four developed further CIN. As it would be unethical to follow such patients longitudinally, we can only assume that these patients would be at risk of developing progressive disease.
Our study conclusively demonstrates an angiogenic change in premalignant disease of the cervix, associated with an increase in the expression of the major angiogenic factor VEGF. Further investigation of the basic mechanism of angiogenesis in CIN is required to clarify its use in detection and to understand its role in disease progression.
